Arbitration Practice Bulletin, 2022, # 1 (published in Russian)

Intellectual Property. Copyright and related rights, 2022, # 1 (published in Russian)

Law and Economics, 2022, #1 (published in Russian)

Law and Economics, 2022, #2 (published in Russian)

Intellectual Property. Industrial Property, 2022, #3 (published in Russian)

Congratulations on the World Intellectual property Day!

In view of massive and not always precise information about amendments into IP enforcement practice in Russia our team decided to prepare a brief digest of the anti-sanction measures and latest amendments introduced into the Russian legislation.

On February 08, 2022, the affiliate session of «A.Zalesov & Partners» Patent & Law Firm - «Patent disputes in pharma: the letter of the law vs extreme necessity»  - took place in the framework of the Distant & Digital conference.

Extension of the Eurasian patent became available for patentees for not so long but already created some legal challenges for patent lawyers. For example, the problem of the impossibility of challenging the legality of the extension of Eurasian patents in national courts has recently become particularly acute and attracted the attention of experts.

Russian IP professionals involved in patent litigation in the pharma field have been intensively discussing a new Ruling of the Presidium of the Intellectual Property Court, which gave new guidelines in the ways of challenging a Supplementary Protection Certificate (SPC), granted with a breach of law. But still, although the Ruling contains crucial conclusions regarding the nature of SPC, it is not clear whether the Court has resolved the topical question of the case.